Eisai
4523.T
#2140
Rank
โ‚น844.20 B
Marketcap
โ‚น2,991
Share price
3.73%
Change (1 day)
18.21%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.59

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น81.29. In 2022 the company made an earnings per share (EPS) of โ‚น150.38 a decrease over its 2021 EPS that were of โ‚น667.61.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.5919.43%
2022โ‚น150.38-77.48%
2021โ‚น667.61-41.88%
2020โ‚น1,149-0.94%
2019โ‚น1,16052.59%
2018โ‚น759.89124.17%
2017โ‚น338.98-49.42%
2016โ‚น670.2537.08%
2015โ‚น488.96-11.75%
2014โ‚น554.03-3.23%
2013โ‚น572.53-18.56%
2012โ‚น703.04-15.51%
2011โ‚น832.13-3.75%
2010โ‚น864.59-1.36%
2009โ‚น876.50